AptarGroup, Inc.
Description
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
About
CEO
Mr. Stephan B. Tanda
Employees
13,000
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Instruments & Supplies
MIC code
XNYS
Address
265 Exchange Drive, Crystal Lake, IL 60014, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Oct 31, 2025 | — | — | — | — |
| Oct 23, 2025 | — | — | — | — |
| Aug 1, 2025 | — | — | — | — |
| Jul 23, 2025 | — | — | — | — |
| May 2, 2025 | — | — | — | — |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 4 | — | 7 |
| Average estimate | — | 1.28 | — | 5.83 |
| Low estimate | — | 1.24 | — | 5.51 |
| High estimate | — | 1.35 | — | 6.20 |
| Last year EPS | — | 1.26 | — | 5.38 |
[stock_revenue_estimate]
Growth estimates
Current qtr
3.860%
Next qtr. (Mar 2025)
1.590%
Current year
12.610%
Next year (Dec 2025)
8.310%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 3.49B | 3.32B | 3.23B | 2.93B | 2.86B |
| Cost of revenue | 2.22B | 2.16B | 2.07B | 1.84B | 1.82B |
| Gross profit | 1.26B | 1.16B | 1.16B | 1.09B | 1.04B |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 565.78M | 544.26M | 551.24M | 500.23M | 454.62M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 449.02M | 385.87M | 370.59M | 365.99M | 392.17M |
| Non operating interest income | |||||
| Income | 4.37M | 2.70M | 3.67M | 958,000 | 4.17M |
| Expense | 40.42M | 40.83M | 30.28M | 33.24M | 35.49M |
| Other income expense | -38.15M | -13.04M | -22.32M | -32.55M | -18.78M |
| Pretax income | 374.83M | 334.70M | 321.66M | 301.16M | 342.07M |
| Tax provision | 90.65M | 95.15M | 78.02M | 87.07M | 99.84M |
| Net income | 284.18M | 239.56M | 243.64M | 214.09M | 242.23M |
| Basic EPS | 4.34 | 3.66 | 3.72 | 3.32 | 3.81 |
| Diluted EPS | 4.25 | 3.59 | 3.61 | 3.21 | 3.66 |
| Basic average shares | 65.62M | 65.40M | 65.66M | 64.42M | 63.57M |
| Diluted average shares | 65.62M | 65.40M | 65.66M | 64.42M | 63.57M |
| EBITDA | 707.43M | 617.94M | 605.32M | 578.13M | 592.58M |
| Net income from continuing op. | 284.18M | 239.56M | 243.64M | 214.09M | 242.23M |
| Minority interests | 311,000 | -267,000 | 459,000 | -50,000 | -25,000 |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 4.45B | 4.20B | 4.14B | 3.99B | 3.56B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 223.64M | 141.73M | 122.93M | 300.14M | 241.97M |
| Other short term investments | — | — | 740,000 | 243,000 | — |
| Accounts receivable | 677.82M | 676.99M | 671.35M | 566.62M | 558.43M |
| Other receivables | — | — | — | — | — |
| Inventory | 513.05M | 486.81M | 441.46M | 379.38M | 375.80M |
| Prepaid assets | — | — | 121.73M | 122.61M | 115.05M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 134.76M | 124.77M | 121.73M | 122.61M | 115.05M |
| Non current assets | |||||
| Properties | 59.07M | 58.68M | 62.45M | 69.85M | 72.38M |
| Land and improvements | 30.09M | 30.20M | 31.44M | 28.33M | 25.13M |
| Machinery furniture equipment | 3.18B | 2.93B | 2.86B | 2.81B | 2.52B |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -2.48B | -2.31B | -2.25B | -2.22B | -1.96B |
| Goodwill | 2.21B | 2.21B | 2.31B | 2.14B | 1.82B |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 283.21M | 315.74M | 362.34M | 344.31M | 291.08M |
| Investments and advances | 49.20M | 52.31M | 59.49M | 50.09M | 8.40M |
| Other non current assets | 69.64M | 57.14M | 48.84M | 59.55M | 47.88M |
| Total liabilities | 2.13B | 2.14B | 2.16B | 2.14B | 1.99B |
| Current liabilities | |||||
| Accounts payable | 328.57M | 320.28M | 285.26M | 243.74M | 192.74M |
| Accrued expenses | 182.00M | 184.30M | 125.34M | 154.53M | 129.63M |
| Short term debt | 458.22M | 122.79M | 289.63M | 117.87M | 110.25M |
| Deferred revenue | 60.51M | 80.24M | 86.95M | 87.05M | 86.82M |
| Tax payable | — | — | — | — | — |
| Pensions | 222.01M | 209.57M | 195.31M | 177.14M | 163.84M |
| Other current liabilities | — | — | — | — | — |
| Non current liabilities | |||||
| Long term debt | 726.46M | 1.10B | 955.03M | 1.11B | 1.14B |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 19.02M | 20.56M | 27.55M | 37.24M | 41.39M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 71.02M | 52.99M | 74.88M | 68.53M | 23.25M |
| Shareholders equity | |||||
| Common stock | 717,000 | 709,000 | 704,000 | 695,000 | 686,000 |
| Retained earnings | 2.11B | 1.93B | 1.79B | 1.64B | 1.52B |
| Other shareholders equity | -308.73M | -341.37M | -316.04M | -281.71M | -341.95M |
| Total shareholders equity | 2.32B | 2.07B | 1.98B | 1.85B | 1.57B |
| Additional paid in capital | 1.04B | 968.62M | 916.53M | 849.16M | 770.60M |
| Treasury stock | 539.40M | 503.27M | 421.20M | 361.58M | 381.24M |
| Minority interest | 14.47M | 14.27M | 15.19M | 396,000 | 336,000 |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | 284.18M | 239.56M | 243.64M | 214.09M | 242.23M | 194.77M | 220.03M | 205.60M | 199.30M | 191.62M | 171.93M | 162.42M | 183.63M | 173.59M | 124.60M | 153.50M | 141.74M | 102.90M | 100.03M | 93.29M | 79.68M | 66.65M | 58.84M | 64.67M | 58.70M | 60.80M | 46.50M | 37.50M | 35.70M | 27.30M | 21.60M | 19.50M |
| Depreciation | 248.59M | 233.71M | 234.85M | 220.30M | 194.55M | 171.75M | 153.09M | 154.80M | 138.89M | 152.22M | 149.96M | 137.02M | 134.24M | 132.96M | 133.01M | 131.15M | 123.47M | 114.61M | 99.24M | 94.49M | 85.85M | 72.14M | 73.58M | 70.95M | 68.70M | 54.40M | 49.90M | 47.90M | 43.50M | 38.40M | 32.10M | 26.20M |
| Deferred Taxes | -19.88M | -12.11M | -14.36M | -8.20M | 8.75M | -23.35M | 2.24M | -11.11M | -7.14M | -18.97M | 6.84M | -9.02M | 2.00M | 503,000 | -1.33M | -1.33M | -11.78M | -10.14M | -6.24M | -2.17M | 4.84M | 6.15M | -4.72M | 3.87M | 5.60M | 5.00M | — | 4.10M | 2.80M | 800,000 | -3.60M | 1.60M |
| Stock-Based Compensation | 41.29M | 40.94M | 38.87M | 34.15M | 23.89M | 19.56M | 18.92M | 19.82M | 20.61M | 19.75M | 14.39M | 12.70M | 13.75M | 11.22M | 9.76M | 11.05M | 14.04M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | — | -8.60M | 2.77M | 5.23M | — | — | 4.71M | — | — | — | — | — | -71,000 | 93,000 | 4.44M | 3.06M | 1.97M | 21.43M | — | — | — | — | — | — | -100,000 | — | — | — | -1.20M | -2.10M | -100,000 | 200,000 |
| Accounts Receivable | 15.43M | -27.94M | -123.25M | 13.46M | 8.81M | -66.97M | -44.66M | -41.72M | -27.76M | -16.32M | -32.81M | 16.69M | -45.00M | -50.14M | 34.29M | -5.29M | -8.35M | -27.38M | 6.02M | -6.65M | -2.53M | 8.77M | 12.84M | -34.39M | -8.40M | -8.60M | -28.80M | -15.80M | -13.30M | -9.60M | -1.90M | -16.80M |
| Accounts Payable | 14.60M | 55.10M | 52.31M | 65.59M | 10.00M | 60.58M | 58.25M | -12.47M | 39.33M | -24.32M | 1.14M | -824,000 | 5.27M | 59.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | -12.08M | -82.45M | -88.58M | 6.46M | -2.36M | -43.49M | -63.19M | -13.89M | -56.48M | 10.44M | -55.58M | -32.66M | -1.56M | -70.63M | -2.31M | 16.37M | -16.60M | -20.73M | -4.75M | -6.81M | -12.12M | -4.01M | -6.32M | -6.61M | -1.40M | -12.00M | -15.40M | -8.30M | -3.30M | -7.40M | -1.30M | -1.60M |
| Operating Cash Flow | 572.13M | 438.20M | 346.25M | 551.08M | 485.87M | 312.84M | 349.39M | 301.03M | 306.75M | 314.42M | 255.88M | 286.33M | 292.27M | 256.74M | 302.46M | 308.52M | 244.48M | 180.69M | 194.30M | 172.15M | 155.72M | 149.69M | 134.23M | 98.49M | 123.10M | 99.60M | 52.20M | 65.40M | 64.20M | 47.40M | 46.80M | 29.10M |
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital Expenditures | 5.35M | 93,000 | 5.23M | 5.26M | 4.30M | 4.47M | 2.04M | 1.69M | 827,000 | 5.11M | 436,000 | 2.63M | 1.84M | 1.40M | 1.67M | 585,000 | 6.23M | -105.41M | -103.70M | -112.89M | -75.24M | -85.41M | -90.74M | -91.03M | -230.60M | -97.90M | -68.00M | -61.90M | -53.50M | -39.50M | -37.60M | -37.30M |
| Net Intangibles | -6.06M | -5.19M | — | -6.09M | -4.81M | -611,000 | — | -2.49M | — | -9,000 | -725,000 | — | — | -459,000 | -308,000 | -1.32M | -1.20M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | -16.57M | -4.10M | -148.42M | -164.18M | -106.33M | -527.92M | — | -201.78M | — | — | -5.26M | -188.12M | -18.03M | -3.01M | -7.58M | -19.50M | 1.50M | -36.79M | -89.76M | — | — | — | — | -2.27M | — | — | — | — | — | — | — | — |
| Purchase of Investments | — | — | -7.37M | -39.87M | -3.53M | -10.00M | -71.16M | — | -32.77M | — | — | — | -3.15M | — | — | -801,000 | — | — | — | — | — | — | — | — | -2.00M | — | -1.20M | — | — | — | -800,000 | -300,000 |
| Sale of Investments | 5.60M | 2.34M | 2.43M | — | 16.49M | — | — | 29.49M | — | — | — | — | — | — | — | — | — | — | 11,000 | — | — | — | — | — | — | — | — | — | — | — | 1.20M | 600,000 |
| Investing Cash Flow | -6.06M | 19.97M | -149.30M | -199.93M | -89.19M | -523.60M | -68.18M | -169.02M | -26.91M | 2.75M | -4.89M | -185.41M | -19.28M | -1.74M | -5.83M | -20.62M | 7.90M | -141.84M | -193.57M | -114.97M | -73.98M | -87.74M | -90.50M | -97.74M | -232.70M | -98.90M | -69.70M | -59.20M | -84.70M | -41.50M | -37.20M | -37.00M |
| Financing Activities | ||||||||||||||||||||||||||||||||
| Long-Term Debt Issuance | 25.93M | 451.97M | 26.63M | 27.19M | 61.38M | 62.23M | 625.63M | 5.96M | 225.24M | 349.34M | 97.18M | 125.00M | 145.34M | 101.62M | 9.63M | 100.65M | 90.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | -154.45M | -303.92M | -82.55M | -101.05M | -120.55M | -102.28M | -165.80M | -55.31M | -244.34M | -778,000 | -28.32M | -137.08M | -50.49M | -84.63M | -26.99M | -174.35M | -26.03M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | -22.75M | -4.01M | -1.72M | -2.77M | — | — | -8.25M | 9.17M | 7.17M | 6.28M | 5.61M | 6.29M | 6.43M | 5.56M | 1.86M | 3.80M | 4.91M | 2.62M | — | — | — | 4.04M | — | — | 100,000 | 100,000 | — | 100,000 | — | 100,000 | 5.00M | -1.90M |
| Financing Cash Flow | -225.54M | -190.61M | -141.42M | -142.28M | -287.97M | -103.03M | 40.89M | -85.06M | -97.07M | -56.75M | -110.48M | -144.02M | 79.94M | -166.27M | -22.41M | -314.66M | -22.90M | -64.80M | -68.17M | -58.15M | -2.83M | -5.72M | -4.94M | -23.80M | -9.40M | -4.50M | -4.30M | -4.30M | -4.50M | 40.30M | 3.40M | -1.90M |
| Other Cash Details | ||||||||||||||||||||||||||||||||
| End Cash Position | 224.14M | 142.73M | 122.93M | 304.97M | 246.97M | 266.82M | 712.64M | 466.29M | 489.90M | 399.76M | 309.86M | 229.76M | 377.62M | 376.43M | 332.96M | 192.07M | 313.74M | 170.58M | 117.64M | 170.37M | 164.98M | 90.21M | 48.01M | 55.56M | 32.40M | — | — | — | — | — | — | — |
| Income Tax Paid | 111.99M | 87.53M | 94.97M | 93.58M | 86.10M | 96.05M | 77.35M | 82.20M | 79.50M | 94.58M | 47.45M | 64.52M | 79.37M | 77.10M | 60.93M | 76.00M | 63.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | 39.60M | 35.51M | 29.07M | 33.32M | 34.42M | 32.01M | 38.84M | 36.27M | 31.66M | 20.35M | 20.68M | 17.46M | 17.12M | 15.70M | 17.54M | 16.06M | 19.98M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 256.84M | 163.00M | 55.51M | 318.11M | 267.38M | 101.77M | 168.11M | 193.82M | 174.44M | 154.38M | 133.87M | 139.84M | 81.35M | 159.43M | 134.56M | 65.29M | 134.32M | 85.10M | 89.63M | 63.48M | 62.51M | 64.67M | 35.66M | 33.87M | -114.40M | -14.80M | 15.00M | 4.50M | 6.20M | 13.10M | 1.20M | 7.40M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Eaton Vance Atlanta Capital SMID-Cap Fd | Sep 30, 2024 | 2,465,010 | 388.73M | 3.70% |
| iShares Core S&P Midcap ETF | Nov 30, 2024 | 2,132,162 | 336.24M | 3.20% |
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 2,101,416 | 331.39M | 3.16% |
| Vanguard Small-Cap Index Fund | Sep 30, 2024 | 1,662,313 | 262.15M | 2.50% |
| Victory Portfolios-Sycamore Established Value Fund | Sep 30, 2024 | 1,525,000 | 240.49M | 2.29% |
| Vanguard Small Cap Value Index Fund | Sep 30, 2024 | 1,124,998 | 177.41M | 1.69% |
| Touchstone Funds Group Tr-Touchstone Mid-Cap Fd | Sep 30, 2024 | 1,040,814 | 164.14M | 1.56% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 986,992 | 155.65M | 1.48% |
| Allspring Special Mid Cap Value Fund | Nov 30, 2024 | 743,200 | 117.20M | 1.12% |
| Neuberger & Berman Genesis Fund | Nov 30, 2024 | 738,315 | 116.43M | 1.11% |
Article
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y
ATR's Q4 top line gains from improved performances of the Pharma and Closures segments.
Feb 10, 2025
Article
International Markets and AptarGroup (ATR): A Deep Dive for Investors
Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Feb 10, 2025
Article
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript
AptarGroup, Inc. (NYSE:ATR ) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2024 Fourth Quarter and Annual Results Conference Call.
Feb 8, 2025
